查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855861

2025年全球数位偏头痛治疗市场报告

Digital Therapeutics Migraine Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，数位偏头痛治疗市场规模呈指数级增长，从2024年的13.7亿美元增长到2025年的16.9亿美元，复合年增长率达23.4%。这段历史性成长时期主要受以下因素驱动：偏头痛盛行率上升、对非药物治疗的需求不断增长、患者越来越偏好无药物疗法、对个人化医疗的日益重视以及数位疗法报销范围的扩大。

预计未来几年，数位偏头痛治疗市场将呈指数级成长，到2029年市场规模将达到39.1亿美元，复合年增长率（CAGR）为23.3%。预测期内的成长主要受以下因素驱动：穿戴式神经调节设备的普及、人们对预防性偏头痛护理意识的提高、政府推动数位医疗的倡议、透过游戏化健康平台增强病人参与，以及保险公司与数位治疗提供者之间伙伴关係的日益增多。预测期内的关键趋势包括：个人化数位治疗方案的推进、行动应用程式与电子健康记录的整合、远距远端医疗偏头痛照护的进步、基于感测器的监测技术的开发，以及循证数位治疗的改进。

日益加剧的压力和生活方式的改变正在推动偏头痛数位治疗市场的扩张。压力和生活方式的改变与日常压力和习惯如何影响个人的身心健康密切相关。由于现代职场环境和快节奏生活的需求，这些改变变得越来越普遍，导致精神压力增加，并扰乱了健康的日常生活。专为偏头痛设计的数位疗法可以透过提供量身定制的行为策略、监测潜在的诱发因素以及鼓励更健康的生活习惯来帮助管理压力和生活方式问题，从而减少偏头痛的发生，并改善整体健康状况。例如，英国家庭血液检测服务公司 Force With Life 在 2024 年 2 月进行的一项调查发现，近五分之一的 16 岁及以上人群每天都承受着压力，女性的比例为 24.5%，高于男性的 15.3%。因此，压力的增加和生活方式的改变正在推动偏头痛数位治疗市场的成长。

在偏头痛数位治疗领域，领先企业正透过电子处方笺系统等技术发展来提升病患照护水准。这些系统使医疗专业人员能够以数位化方式开立、传输和管理处方笺，从而提高准确性，减少用药错误，并提升处方和配药流程的效率。 2025年4月，美国製药公司Tonix Pharmaceuticals Holding Corporation推出了TONIX ONE，这是一个旨在帮助管理偏头痛症状的整合式数位平台。该平台提供客製化工具、教育材料和支援服务，旨在提高患者的知识水平和自我护理能力。它还鼓励使用者积极参与治疗，并促进持续的健康管理。此外，TONIX ONE也加强了病患与医疗服务提供者之间的沟通，改善了协作，提升了整体照护体验。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球数位偏头痛治疗：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球数位偏头痛治疗市场：成长率分析
  • 全球数位偏头痛治疗市场表现：规模与成长，2019-2024年
  • 全球数位偏头痛治疗市场预测：规模与成长，2024-2029年，2034年
  • 全球数位偏头痛治疗：潜在市场规模 (TAM)

第六章 市场细分

  • 全球数位偏头痛治疗市场依产品类型、表现及预测划分，2019-2024年、2024-2029年、2034年
  • 软体
  • 装置
  • 服务
  • 全球数位偏头痛治疗市场依患者类型、疗效及预测划分，2019-2024年、2024-2029年、2034年
  • 成人
  • 儿童
  • 全球数位偏头痛治疗市场按应用、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 预防
  • 急性治疗
  • 病患教育
  • 其他用途
  • 全球数位偏头痛治疗市场依通路、绩效及预测划分，2019-2024年、2024-2029年、2034年
  • 在线的
  • 离线
  • 全球数位偏头痛治疗市场按最终用户、表现和预测划分，2019-2024年、2024-2029年、2034年
  • 医院
  • 诊所
  • 居家照护
  • 其他最终用户
  • 全球数位偏头痛治疗市场：按软体、类型、表现和预测进行细分，2019-2024年、2024-2029年、2034年
  • 行动应用
  • 网路平台
  • 云端基础的平台
  • 穿戴式装置整合软体
  • 全球数位偏头痛治疗市场：按设备、类型、性能和预测进行细分，2019-2024年、2024-2029年、2034年
  • 穿戴式装置
  • 神经刺激设备
  • 监测设备
  • 生物感测器
  • 全球数位偏头痛治疗市场：按服务、类型、表现和预测进行细分，2019-2024年、2024-2029年、2034年
  • 远距咨询服务
  • 治疗管理服务
  • 病人支援服务
  • 数据分析服务

第七章 区域和国家分析

  • 全球数位偏头痛治疗市场：按地区、绩效和预测划分，2019-2024年、2024-2029年、2034年
  • 全球数位偏头痛治疗市场：国家/地区、绩效及预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 偏头痛数位治疗市场：竞争格局
  • 数位偏头痛治疗市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Sword Health Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Biofourmis Inc.
  • Click Therapeutics Inc.
  • Sidekick Health
  • Kaia Health Software GmbH
  • Salvia BioElectronics
  • Theranica Bio-Electronics Ltd.
  • Cefaly Technology SA
  • Neurolief Ltd.
  • Aptar Digital Health
  • NeuroMetrix Inc.
  • Happify Health
  • Neura Health
  • Relivion MG
  • UpScriptHealth
  • N1-Headache

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年数位偏头痛治疗市场：提供新机会的国家
  • 2029年数位偏头痛治疗市场：蕴藏新机会的细分市场
  • 2029年数位偏头痛治疗市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38510

Digital therapeutics for migraine are evidence-based digital solutions developed to prevent, manage, or treat migraine symptoms through software programs, offering personalized guidance and monitoring to help patients reduce attack frequency and severity. They track triggers and provide real-time feedback to enhance outcomes, complement traditional therapies, and empower patients to actively manage their migraines.

The primary product categories of digital therapeutics for migraine include software, devices, and services. Software consists of digital platforms and applications that deliver evidence-based interventions for migraine management. Patient groups include adults and children, and applications cover prevention, acute treatment, patient education, and more. These products are distributed through both online and offline channels and are utilized by key end-users such as hospitals, clinics, and home care providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The digital therapeutics migraine market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics migraine market statistics, including the digital therapeutics migraine industry global market size, regional shares, competitors with the digital therapeutics migraine market share, detailed digital therapeutics migraine market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics migraine industry. This digital therapeutics migraine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The digital therapeutics migraine market size has grown exponentially in recent years. It will grow from $1.37 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 23.4%. The growth during the historic period is driven by the increasing prevalence of migraine, the rising demand for non-drug treatments, the growing patient preference for drug-free options, the heightened focus on personalized healthcare, and the expanding availability of reimbursement for digital therapeutics.

The digital therapeutics migraine market size is expected to see exponential growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 23.3%. The growth during the forecast period is supported by the increasing adoption of wearable neuromodulation devices, greater awareness of preventive migraine care, the rise of government initiatives promoting digital health, enhanced patient engagement through gamified health platforms, and the growing partnerships between insurers and digital therapeutics providers. Key trends in the forecast period include advancements in personalized digital treatment plans, integration of mobile applications with electronic health records, progress in telemedicine-based migraine care, development of sensor-based monitoring technologies, and improvements in evidence-based digital therapies.

The growing levels of stress and lifestyle disruptions are contributing to the expansion of the digital therapeutics migraine market. Stress and lifestyle changes relate to how everyday pressures and habits affect an individual's physical and mental health. These changes are becoming more common due to the demands of modern work environments and fast-paced living, which lead to increased mental strain and interfere with healthy routines. Digital therapeutics designed for migraine support the management of stress and lifestyle issues by offering tailored behavioral strategies, monitoring potential triggers, and encouraging healthier habits that help reduce the occurrence of migraines and enhance overall well-being. For example, in February 2024, a survey conducted in the United Kingdom by Forthwithlife, a provider of at-home blood testing services, found that nearly one in five individuals aged sixteen and older experiences daily stress, with a higher percentage among women at 24.5 percent compared to 15.3 percent among men. As a result, the rise in stress and lifestyle changes is driving growth in the digital therapeutics migraine market.

Key companies within the digital therapeutics migraine space are advancing patient care through the development of technologies such as electronic prescription systems. These systems allow healthcare professionals to issue, send, and manage prescriptions digitally, offering greater precision, fewer medication-related errors, and improved efficiency in the prescribing and dispensing processes. In April 2025, Tonix Pharmaceuticals Holding Corp., a pharmaceutical company based in the United States, launched TONIX ONE, an integrated digital platform created to assist individuals in managing their migraine condition. This platform offers tailored tools, educational materials, and support services aimed at improving patient knowledge and self-care practices. It also empowers users to take an active role in their treatment, promoting consistent health management. Moreover, TONIX ONE enhances communication between patients and healthcare providers, improving coordination and the overall care experience.

In February 2024, Aptar Digital Health, LLC, a digital health company based in the United States, acquired Healint for an undisclosed sum. This acquisition allows Aptar to broaden its offerings in the field of neurology and strengthen its digital health capabilities. Healint, based in Singapore, provides digital tools for migraine management through its Migraine Buddy application, which uses artificial intelligence and sensor technology to support users in tracking and managing their symptoms.

Major players in the digital therapeutics migraine market are Pfizer Inc., Novartis AG, Eli Lilly and Company, Dr. Reddy's Laboratories Ltd., Sword Health, Biofourmis Inc., Click Therapeutics Inc., Sidekick Health, Kaia Health Software GmbH, Salvia BioElectronics, Theranica Bio-Electronics Ltd., Cefaly Technology S.A., Neurolief Ltd., Aptar Digital Health, NeuroMetrix Inc., Happify Health, Neura Health, Relivion MG, UpScriptHealth, N1-Headache.

North America was the largest region in the digital therapeutics migraine market in 2024. The regions covered in digital therapeutics migraine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics migraine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics migraine market consists of revenues earned by entities by providing services such as mobile app-based migraine management services, biofeedback therapy services, wearable device integration services, nutritional guidance services, and remote monitoring programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics migraine market also includes sales of digital apps, and telehealth technology. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Migraine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics migraine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics migraine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics migraine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type; Software; Devices; Services

2) By Patient Type; Adult; Pediatric

3) By Application; Prevention; Acute Treatment; Patient Education; Other Applications

4) By Distribution Channel; Online; Offline

5) By End-User; Hospitals; Clinics; Homecare; Other End-Users

  • Subsegments:

1) By Software; Mobile Application; Web Platform; Cloud-Based Platform; Wearable Integration Software

2) By Devices; Wearable Devices; Neurostimulation Devices; Monitoring Devices; Biosensors

3) By Services; Teleconsultation Services; Therapy Management Services; Patient Support Services; Data Analytics Services

  • Companies Mentioned: Pfizer Inc.; Novartis AG; Eli Lilly and Company; Dr. Reddy's Laboratories Ltd.; Sword Health; Biofourmis Inc.; Click Therapeutics Inc.; Sidekick Health; Kaia Health Software GmbH; Salvia BioElectronics; Theranica Bio-Electronics Ltd.; Cefaly Technology S.A.; Neurolief Ltd.; Aptar Digital Health; NeuroMetrix Inc.; Happify Health; Neura Health; Relivion MG; UpScriptHealth; N1-Headache
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Therapeutics Migraine Market Characteristics

3. Digital Therapeutics Migraine Market Trends And Strategies

4. Digital Therapeutics Migraine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics Migraine Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Digital Therapeutics Migraine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Digital Therapeutics Migraine Market Growth Rate Analysis
  • 5.4. Global Digital Therapeutics Migraine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Digital Therapeutics Migraine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Digital Therapeutics Migraine Total Addressable Market (TAM)

6. Digital Therapeutics Migraine Market Segmentation

  • 6.1. Global Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Devices
  • Services
  • 6.2. Global Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adult
  • Pediatric
  • 6.3. Global Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prevention
  • Acute Treatment
  • Patient Education
  • Other Applications
  • 6.4. Global Digital Therapeutics Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online
  • Offline
  • 6.5. Global Digital Therapeutics Migraine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare
  • Other End-Users
  • 6.6. Global Digital Therapeutics Migraine Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mobile Application
  • Web Platform
  • Cloud-Based Platform
  • Wearable Integration Software
  • 6.7. Global Digital Therapeutics Migraine Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable Devices
  • Neurostimulation Devices
  • Monitoring Devices
  • Biosensors
  • 6.8. Global Digital Therapeutics Migraine Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Teleconsultation Services
  • Therapy Management Services
  • Patient Support Services
  • Data Analytics Services

7. Digital Therapeutics Migraine Market Regional And Country Analysis

  • 7.1. Global Digital Therapeutics Migraine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Digital Therapeutics Migraine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics Migraine Market

  • 8.1. Asia-Pacific Digital Therapeutics Migraine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics Migraine Market

  • 9.1. China Digital Therapeutics Migraine Market Overview
  • 9.2. China Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics Migraine Market

  • 10.1. India Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics Migraine Market

  • 11.1. Japan Digital Therapeutics Migraine Market Overview
  • 11.2. Japan Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics Migraine Market

  • 12.1. Australia Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics Migraine Market

  • 13.1. Indonesia Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics Migraine Market

  • 14.1. South Korea Digital Therapeutics Migraine Market Overview
  • 14.2. South Korea Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics Migraine Market

  • 15.1. Western Europe Digital Therapeutics Migraine Market Overview
  • 15.2. Western Europe Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics Migraine Market

  • 16.1. UK Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics Migraine Market

  • 17.1. Germany Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics Migraine Market

  • 18.1. France Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics Migraine Market

  • 19.1. Italy Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics Migraine Market

  • 20.1. Spain Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics Migraine Market

  • 21.1. Eastern Europe Digital Therapeutics Migraine Market Overview
  • 21.2. Eastern Europe Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics Migraine Market

  • 22.1. Russia Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics Migraine Market

  • 23.1. North America Digital Therapeutics Migraine Market Overview
  • 23.2. North America Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics Migraine Market

  • 24.1. USA Digital Therapeutics Migraine Market Overview
  • 24.2. USA Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics Migraine Market

  • 25.1. Canada Digital Therapeutics Migraine Market Overview
  • 25.2. Canada Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics Migraine Market

  • 26.1. South America Digital Therapeutics Migraine Market Overview
  • 26.2. South America Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics Migraine Market

  • 27.1. Brazil Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics Migraine Market

  • 28.1. Middle East Digital Therapeutics Migraine Market Overview
  • 28.2. Middle East Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics Migraine Market

  • 29.1. Africa Digital Therapeutics Migraine Market Overview
  • 29.2. Africa Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics Migraine Market Competitive Landscape And Company Profiles

  • 30.1. Digital Therapeutics Migraine Market Competitive Landscape
  • 30.2. Digital Therapeutics Migraine Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sword Health Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics Migraine Market Other Major And Innovative Companies

  • 31.1. Biofourmis Inc.
  • 31.2. Click Therapeutics Inc.
  • 31.3. Sidekick Health
  • 31.4. Kaia Health Software GmbH
  • 31.5. Salvia BioElectronics
  • 31.6. Theranica Bio-Electronics Ltd.
  • 31.7. Cefaly Technology S.A.
  • 31.8. Neurolief Ltd.
  • 31.9. Aptar Digital Health
  • 31.10. NeuroMetrix Inc.
  • 31.11. Happify Health
  • 31.12. Neura Health
  • 31.13. Relivion MG
  • 31.14. UpScriptHealth
  • 31.15. N1-Headache

32. Global Digital Therapeutics Migraine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics Migraine Market

34. Recent Developments In The Digital Therapeutics Migraine Market

35. Digital Therapeutics Migraine Market High Potential Countries, Segments and Strategies

  • 35.1 Digital Therapeutics Migraine Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Digital Therapeutics Migraine Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Digital Therapeutics Migraine Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer